Just as you, Dew, AF and the like would have dismissed a stat sig pancreatic trial as bogus had it been. I laugh at your opinions, and see right through your presence.
I may question MOA, but at least when I speak its not with a forked tongue.
Why do so many and especially Biovalue board guys harp on stat stig for phase II trials.,are most phase II trials designed to be stat sig? I thought most were designed to show safety and and enough activity to be approved to go to ph III.
Has there been anything that has shown to be effective for pancreatic that isn't some form of chemo agent? My guess is if Bavi shows good lung data and partners then we will see Bavi down the road for pancreatic based on subsets or in combination with Gem and Abraxane
News 
Market Data 
Discover 
